ICD-10-PCS Codes

• 1 3E05002 (INTRODUCTION OF HIGH-DOSE INTERLEUKIN-2 INTO PERIPHERAL ARTERY, OPEN APPROACH)

• 2 3E05003 (INTRODUCTION OF LOW-DOSE INTERLEUKIN-2 INTO PERIPHERAL ARTERY, OPEN APPROACH)

• 3 3E05005 (INTRODUCTION OF OTHER ANTINEOPLASTIC INTO PERIPHERAL ARTERY, OPEN APPROACH)

• 4 3E0500M (INTRODUCTION OF ANTINEOPLASTIC, MONOCLONAL ANTIBODY, INTO PERIPHERAL ARTERY, OPEN APPROACH)

• 5 3E0500P (INTRODUCTION OF CLOFARABINE INTO PERIPHERAL ARTERY, OPEN APPROACH)

• 6 3E05016 (INTRODUCTION OF RECOMBINANT HUMAN-ACTIVATED PROTEIN C INTO PERIPHERAL ARTERY, OPEN)

• 7 3E05017 (INTRODUCTION OF OTHER THROMBOLYTIC INTO PERIPHERAL ARTERY, OPEN APPROACH)

• 8 3E05028 (INTRODUCTION OF OXAZOLIDINONES INTO PERIPHERAL ARTERY, OPEN APPROACH)

• 9 3E05029 (INTRODUCTION OF OTHER ANTI-INFECTIVE INTO PERIPHERAL ARTERY, OPEN APPROACH)

• 10 3E0503Z (INTRODUCTION OF ANTI-INFLAMMATORY INTO PERIPHERAL ARTERY, OPEN APPROACH)

• 11 3E0504Z (INTRODUCTION OF SERUM, TOXOID AND VACCINE INTO PERIPHERAL ARTERY, OPEN APPROACH)

• 12 3E0506Z (INTRODUCTION OF NUTRITIONAL SUBSTANCE INTO PERIPHERAL ARTERY, OPEN APPROACH)

• 13 3E0507Z (INTRODUCTION OF ELECTROLYTIC AND WATER BALANCE SUBSTANCE INTO PERIPHERAL ARTERY, OPEN APPROACH)

• 14 3E050FZ (INTRODUCTION OF INTRACIRCULATORY ANESTHETIC INTO PERIPHERAL ARTERY, OPEN APPROACH)

• 15 3E050GC (INTRODUCTION OF OTHER THERAPEUTIC SUBSTANCE INTO PERIPHERAL ARTERY, OPEN APPROACH)

• 16 3E050GN (INTRODUCTION OF BLOOD BRAIN BARRIER DISRUPTION SUBSTANCE INTO PERIPHERAL ARTERY, OPEN APPROACH)

• 17 3E050HZ (INTRODUCTION OF RADIOACTIVE SUBSTANCE INTO PERIPHERAL ARTERY, OPEN APPROACH)

• 18 3E050KZ (INTRODUCTION OF OTHER DIAGNOSTIC SUBSTANCE INTO PERIPHERAL ARTERY, OPEN APPROACH)

• 19 3E050NZ (INTRODUCTION OF ANALGESICS, HYPNOTICS, SEDATIVES INTO PERIPHERAL ARTERY, OPEN APPROACH)

• 20 3E050PZ (INTRODUCTION OF PLATELET INHIBITOR INTO PERIPHERAL ARTERY, OPEN APPROACH)

• 21 3E050RZ (INTRODUCTION OF ANTIARRHYTHMIC INTO PERIPHERAL ARTERY, OPEN APPROACH)

• 22 3E050TZ (INTRODUCTION OF DESTRUCTIVE AGENT INTO PERIPHERAL ARTERY, OPEN APPROACH)

• 23 3E050VG (INTRODUCTION OF INSULIN INTO PERIPHERAL ARTERY, OPEN APPROACH)

• 24 3E050VH (INTRODUCTION OF HUMAN B-TYPE NATRIURETIC PEPTIDE INTO PERIPHERAL ARTERY, OPEN APPROACH)

• 25 3E050VJ (INTRODUCTION OF OTHER HORMONE INTO PERIPHERAL ARTERY, OPEN APPROACH)

• 26 3E050WK (INTRODUCTION OF IMMUNOSTIMULATOR INTO PERIPHERAL ARTERY, OPEN)

• 27 3E050WL (INTRODUCTION OF IMMUNOSUPPRESSIVE INTO PERIPHERAL ARTERY, OPEN)

• 28 3E050XZ (INTRODUCTION OF VASOPRESSOR INTO PERIPHERAL ARTERY, OPEN APPROACH)

• 29 3E05302 (INTRODUCTION OF HIGH-DOSE INTERLEUKIN-2 INTO PERIPHERAL ARTERY, PERCUTANEOUS APPROACH)

• 30 3E05303 (INTRODUCTION OF LOW-DOSE INTERLEUKIN-2 INTO PERIPHERAL ARTERY, PERCUTANEOUS APPROACH)

• 31 3E05305 (INTRODUCTION OF OTHER ANTINEOPLASTIC INTO PERIPHERAL ARTERY, PERCUTANEOUS APPROACH)

• 32 3E0530M (INTRODUCTION OF ANTINEOPLASTIC, MONOCLONAL ANTIBODY, INTO PERIPHERAL ARTERY, PERCUTANEOUS APPROACH)

• 33 3E0530P (INTRODUCTION OF CLOFARABINE INTO PERIPHERAL ARTERY, PERCUTANEOUS APPROACH)

• 34 3E05316 (INTRODUCTION OF RECOMBINANT HUMAN-ACTIVATED PROTEIN C INTO PERIPHERAL ARTERY, PERCUTANEOUS)

• 35 3E05317 (INTRODUCTION OF OTHER THROMBOLYTIC INTO PERIPHERAL ARTERY, PERCUTANEOUS APPROACH)

• 36 3E05328 (INTRODUCTION OF OXAZOLIDINONES INTO PERIPHERAL ARTERY, PERCUTANEOUS APPROACH)

• 37 3E05329 (INTRODUCTION OF OTHER ANTI-INFECTIVE INTO PERIPHERAL ARTERY, PERCUTANEOUS APPROACH)

• 38 3E0533Z (INTRODUCTION OF ANTI-INFLAMMATORY INTO PERIPHERAL ARTERY, PERCUTANEOUS APPROACH)

• 39 3E0534Z (INTRODUCTION OF SERUM, TOXOID AND VACCINE INTO PERIPHERAL ARTERY, PERCUTANEOUS APPROACH)

• 40 3E0536Z (INTRODUCTION OF NUTRITIONAL SUBSTANCE INTO PERIPHERAL ARTERY, PERCUTANEOUS APPROACH)

• 41 3E0537Z (INTRODUCTION OF ELECTROLYTIC AND WATER BALANCE SUBSTANCE INTO PERIPHERAL ARTERY, PERCUTANEOUS APPROACH)

• 42 3E053FZ (INTRODUCTION OF INTRACIRCULATORY ANESTHETIC INTO PERIPHERAL ARTERY, PERCUTANEOUS APPROACH)

• 43 3E053GC (INTRODUCTION OF OTHER THERAPEUTIC SUBSTANCE INTO PERIPHERAL ARTERY, PERCUTANEOUS APPROACH)

• 44 3E053GN (INTRODUCTION OF BLOOD BRAIN BARRIER DISRUPTION SUBSTANCE INTO PERIPHERAL ARTERY, PERCUTANEOUS APPROACH)

• 45 3E053HZ (INTRODUCTION OF RADIOACTIVE SUBSTANCE INTO PERIPHERAL ARTERY, PERCUTANEOUS APPROACH)

• 46 3E053KZ (INTRODUCTION OF OTHER DIAGNOSTIC SUBSTANCE INTO PERIPHERAL ARTERY, PERCUTANEOUS APPROACH)

• 47 3E053NZ (INTRODUCTION OF ANALGESICS, HYPNOTICS, SEDATIVES INTO PERIPHERAL ARTERY, PERCUTANEOUS APPROACH)

• 48 3E053PZ (INTRODUCTION OF PLATELET INHIBITOR INTO PERIPHERAL ARTERY, PERCUTANEOUS APPROACH)

• 49 3E053RZ (INTRODUCTION OF ANTIARRHYTHMIC INTO PERIPHERAL ARTERY, PERCUTANEOUS APPROACH)

• 50 3E053TZ (INTRODUCTION OF DESTRUCTIVE AGENT INTO PERIPHERAL ARTERY, PERCUTANEOUS APPROACH)

• 51 3E053VG (INTRODUCTION OF INSULIN INTO PERIPHERAL ARTERY, PERCUTANEOUS APPROACH)

• 52 3E053VH (INTRODUCTION OF HUMAN B-TYPE NATRIURETIC PEPTIDE INTO PERIPHERAL ARTERY, PERCUTANEOUS APPROACH)

• 53 3E053VJ (INTRODUCTION OF OTHER HORMONE INTO PERIPHERAL ARTERY, PERCUTANEOUS APPROACH)

• 54 3E053WK (INTRODUCTION OF IMMUNOSTIMULATOR INTO PERIPHERAL ARTERY, PERCUTANEOUS)

• 55 3E053WL (INTRODUCTION OF IMMUNOSUPPRESSIVE INTO PERIPHERAL ARTERY, PERCUTANEOUS)

• 56 3E053XZ (INTRODUCTION OF VASOPRESSOR INTO PERIPHERAL ARTERY, PERCUTANEOUS APPROACH)